“▶ YEOTOP4.COM ◀ 여탑수색동오피ば수색동안마ひ수색동립카페☩수색동출장←수색동오피◀수색동키스방ⅱ수색동건마”的搜索结果，显示 211-220 项，共有 9825 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Patients randomized to B+R will receive 6 cycles of treatment consisting of a rituximab infusion (Cycle 1: 375 mg/m2; Cycles 2-6: 500 mg/m2) on Day 1 and ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Patients randomized to B+R will receive 6 cycles of treatment consisting of a rituximab infusion (Cycle 1: 375 mg/m2; Cycles 2-6: 500 mg/m2) on Day 1 and ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   [1, 2] The solid tumor stroma acts as an immunosuppressive cloud that impedes the homing of peripheral CAR T-cells into the tumor microenvironment (TME).

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This is a phase II multi-center study of nab-paclitaxel, gemcitabine and cisplatin (NGC triple regimen) as preoperative therapy in potentially resectable ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. Levels of bladder cancer-derived extracellular vesicles become undetectable after radical cystectomy in patients with localized bladder cancer.

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This phase II trial studies how well olaparib works in treating patients with biliary tract cancer that has spread to other places in the body (metastatic) and ...

7. 神经科- 临床试验- 妙佑医疗国际

   ... 2-year progression free survival (PFS) rate as compared to ACNS0122. Also, to improve disease control by decreasing the number of spinal relapses for ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This phase II trial studies the effect of pembrolizumab, dabrafenib, and trametinib before surgery in treating patients with BRAF V600E-mutated anaplastic ...

9. 神经外科- 临床试验- 妙佑医疗国际

   Cohort 3 includes (1) CMVpp65 absent and (2) CMVpp65 present GBM.. Patients in all subcohorts except 1.11 and 1.12 currently have unresectable advanced or ...

10. 神经科- 临床试验- 妙佑医疗国际

    ... 2-hydroxyglutarate (2HG) and, therefore, differentiate between IDH-mutant and wild-type gliomas. Peripheral Nerve Stimulation Therapy for Atrial ...